One Formula, One Platform: Inside the Preclinical Milestone Behind Conexeu’s Move Into Medical Aesthetics
Issued on behalf of Conexeu Sciences Inc.Conexeu Sciences Inc. (NASDAQ: CNXU) completed the 12-month P.R.O.O.F phase of its CXU preclinical...
Read moreDetails